Haemonetics | HAE - Capital Ordinário





Capital Ordinário Alterar Data
Baxter International USD 517M 549K 2026-06
Becton, Dickinson and Co. USD 370.59M 95.05M 2026-06
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 195.11M 14K 2026-03
Fresenius EUR 563.24M 0 2026-06
Fresenius Medical Care EUR 266.11M 3.98M 2026-06
Globus Medical USD 135.67M 611K 2026-03
Haemonetics USD 45.47M 1.36M 2026-06
ICU Medical USD 24.99M 305K 2026-03
Intuitive Surgical USD 354.16M 1.01M 2026-06
Medtronic USD 1.28B 1.38M 2025-12
Merit Medical Systems USD 59.71M 55K 2026-06
Neogen USD 217.7M 27K 2026-03
OraSure Technologies USD 70.39M 1.87M 2025-12
Plus Therapeutics USD 275K 138.4M 2026-03
Quidel USD 68.1M 200K 2026-03
ResMed USD 145.06M 45.78M 2026-06
STAAR Surgical USD 50.12M 343K 2026-06
Steris USD 98.07M 72K 2026-03
Stryker USD 383.4M 416K 2026-06
Teleflex USD 44.26M 70K 2026-03
Terumo JPY 1.48B 19K 2026-06
Thermo Fisher Scientific USD 371.62M 1000 2026-06
US Physical Therapy USD 15.23M 107.81K 2026-03
Zimmer Biomet Holdings USD 193.4M 2.1M 2026-06